The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer’s disease
Abstract
The beginnings of late onset Alzheimer's disease (LOAD) are still unknown; however, the progressive and latent nature of neurodegeneration suggests that the triggering event occurs earlier in life. Aging primates exposed to lead (Pb) as infants exhibited an overexpression of the amyloid-β protein precursor (AβPP), amyloid-β (Aβ) and enhanced pathologic neurodegeneration. In this study, we measured the latent expression of a wide array of brain-specific genes and explored whether epigenetic pathways mediated such latent molecular and pathological changes. We analyzed the levels of proteins associated with DNA methylation, i.e., DNA methyltransferase 1 (Dnmt1), DNA methyltransferase3a (Dnmt3a), methyl-CpG binding protein-2 (MeCP2) and those involved in histone modifications (acetylated and methylated histones). We monitored the expression profiles of these intermediates across the lifespan and analyzed their levels in 23-year-old primate brains exposed to Pb as infants. Developmental Pb exposure altered the gene expression of the arrayed genes, which were predominately repressed, with fewer upregulated genes. The latent induction and repression of genes was accompanied by a significant decrease in the protein levels of Dnmts, MeCP2, and proteins involved in histone modifications. The attenuation of DNA methylation enzymes is consistent with hypomethylating effects, which promote upregulation of the genes, while the alterations in the histone modifiers are associated with the repression of genes. Hence, we deduce that early life exposure to Pb can reprogram gene expression resulting in both upregulation and down-regulation of genes through alternate epigenetic pathways contributing to an enhancement in neurodegeneration in old age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is evidence to implicate DNA methylation as a potential mechanism by which developmental lead exposure alters neurodevelopment and function throughout life [ 121 , 122 ].”
From DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? (2016) · cites this paper as [121]
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. P. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,288
Histone and chromatin cross-talk
Fischle, W., Wang, Y., & Allis, C. D. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00013-9 · Cited by 1,239
Histone modifications in transcriptional regulation
Berger, S. L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00279-4 · Cited by 1,222
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Vaissière, T., Sawan, C., & Herceg, Z. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.02.004 · Cited by 657
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 598
Litt, M. D., Simpson, M., Gaszner, M., Allis, C. D., & Felsenfeld, G. (2001) · Science · doi:10.1126/science.1064413 · Cited by 579
Wu, J., Basha, R. M., Brock, B., Cox, D. P., Cardozo‐Pelaez, F., McPherson, C. A., Harry, J., Rice, D. C., Maloney, B., Chen, D., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4405-07.2008 · Cited by 473
Self-citationTakiguchi, M., Achanzar, W. E., Qu, W., Li, G., & Waalkes, M. P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00062-4 · Cited by 457
Fetal origins of cardiovascular disease
Barker, D. J. P. (1999) · Annals of Medicine · doi:10.1080/07853890.1999.11904392 · Cited by 426
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Sanchez-Mejia, R. O., Newman, J. W. I., Toh, S., Yu, G.-Q., Zhou, Y., Halabisky, B., Cissé, M., Scearce-Levie, K. A., Cheng, I. H.-J., Gan, L., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2213 · Cited by 362
Basha, R. M., Wei, W., Bakheet, S. A., Benitez, N. B., Siddiqi, H. K., Ge, Y., Lahiri, D. K., & Zawia, N. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4335-04.2005 · Cited by 353
Self-citationGenetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Migliore, L., & Coppedè, F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.011 · Cited by 331
The promoter of Alzheimer's disease amyloid A4 precursor gene.
Salbaum, J. M., Weidemann, A., Lemaire, H.-G., Masters, C. L., & Beyreuther, K. T. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03136.x · Cited by 311
Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease
Francis, Y. I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D. S., & Arancio, O. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1134 · Cited by 306
Castillo, S. O., Baffi, J., Palkovits, M., Goldstein, D. S., Kopin, I. J., Witta, J., Magnuson, M. A., & Nikodem, V. M. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0673 · Cited by 292
Obstetric complications and risk of schizophrenia
Thomas, H. V., Dalman, C., David, A. S., Gentz, J., Lewis, G., & Allebeck, P. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.5.409 · Cited by 277
Epigenetic Regulation of Neural Gene Expression and Neuronal Function
Feng, J., Fouse, S. D., & Fan, G. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180457635 · Cited by 271
Nickel Ions Increase Histone H3 Lysine 9 Dimethylation and Induce Transgene Silencing
Chen, H., Ke, Q., Kluz, T., Yan, Y., & Costa, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3728-3737.2006 · Cited by 229
van Erp, T. G. M., Saleh, P. A., Rosso, I. M., HUTTUNEN, M. O., Lönnqvist, J. K., Pirkola, T., Salonen, O. L. M., Valanne, L. K., Poutanen, V.-P., Standertskjöld-Nordenstam, C.-G., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1514 · Cited by 227
Abdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216
Epigenetic biomarkers for human cancer: The time is now
Mulero‐Navarro, S., & Esteller, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.03.001 · Cited by 209
Phospholipases A2 and Inflammatory Responses in the Central Nervous System
Sun, G. Y., Shelat, P. B., Jensen, M. B., He, Y., Sun, A. Y., & Simonyi, Á. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8092-z · Cited by 197
Lahiri, D. K., Farlow, M. R., Sambamurti, K., Greig, N. H., Giacobini, E., & Schneider, L. S. S. (2003) · Current Drug Targets · doi:10.2174/1389450033346957 · Cited by 185
Amyloid Protein and Alzheimer's Disease
Selkoe, D. J. (1991) · Scientific American · doi:10.1038/scientificamerican1191-68 · Cited by 183
Co‐operative regulation of endocytosis by three RAB5 isoforms
Bucci, C., Lütcke, A., Steele‐Mortimer, O., Olkkonen, V. M., Dupree, P., Chiariello, M., Bruni, C. B., Simons, K., & Zerial, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00477-q · Cited by 162
Cumulative Lead Exposure and Cognitive Performance Among Elderly Men
Weisskopf, M. G., Proctor, S. P., Wright, R. O., Schwartz, J. D., Spiro, A., Sparrow, D., Nie, H., & Hu, H. (2006) · Epidemiology · doi:10.1097/01.ede.0000248237.35363.29 · Cited by 159
Relations of Bone and Blood Lead to Cognitive Function: The VA Normative Aging Study
Payton, M., Riggs, K. M., Spiro, A., Weiss, S. T., & Hu, H. (1998) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(97)00075-5 · Cited by 158
Boksa, P., & El-Khodor, B. F. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00012-5 · Cited by 157
Kriem, B., Sponne, I., Fifre, A., Malaplate, C., Lozac'h‐Pillot, K., Koziel, V., Yen, F. T., Bihain, B. E., Oster, T., Olivier, J. L., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1807fje · Cited by 157
β-Amyloid-induced Dynamin 1 Depletion in Hippocampal Neurons
Kelly, B. L., Vassar, R. J., & Ferreira, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503259200 · Cited by 129
High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients
Schmidtke, K., & Hermeneit, S. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005509 · Cited by 127
Mathieu-Kia, A.-M., Fan, L.-Q., Kreek, M. J., Simon, E. J., & Hiller, J. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03302-3 · Cited by 118
Lead Exposure Biomarkers and Mini-Mental Status Exam Scores in Older Men
Wright, R. O., Tsaih, S.-W., Schwartz, J. D., Spiro, A., McDonald, K. Q., Weiss, S. T., & Hu, H. (2003) · Epidemiology · doi:10.1097/01.ede.0000081988.85964.db · Cited by 111
Cumulative Exposure to Lead in Relation to Cognitive Function in Older Women
Weuve, J., Korrick, S., Weisskopf, M. G., RYAN, L. M., Schwartz, J. D., Nie, H., Grodstein, F., & Hu, H. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11846 · Cited by 110
Watanabe, D., Uchiyama, K., & Hanaoka, K. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.053 · Cited by 102
Neurofibrillary Changes Following Childhood Lead Encephalopathy
Niklowitz, W. J., & Mandybur, T. I. (1975) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197509000-00006 · Cited by 100
Genetic risk of Alzheimer's disease: advising relatives
Liddell, M. B., Lovestone, S., & Owen, M. J. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.7 · Cited by 75
A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Sambamurti, K., Suram, A., Venugopal, C., Prakasam, A., Zhou, Y., Lahiri, D. K., & Greig, N. H. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697142 · Cited by 62
Effects of maternal lead administration on monoaminergic, GABAergic and glutamatergic systems
Leret, M. L., Garcia-Uceda, F., & Antonio, M. T. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00819-5 · Cited by 61
Rice, D. C. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90251-o · Cited by 54
Regional alterations of brain biogenic amines in young rats following chronic lead exposure
Dubas, T. C., Stevenson, A., Singhal, R. L., & Hrdina, P. D. (1978) · Toxicology · doi:10.1016/0300-483x(78)90044-6 · Cited by 53
Haraguchi, T., Ishizu, H., Takehisa, Y., Kawai, K., Yokota, O., Terada, S., Tsuchiya, K., Ikeda, K., Morita, K., Horike, T., et al. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00006 · Cited by 41
Tanzi, R. E., & Bertram, L. (2008) · Nature · doi:10.1038/454706a · Cited by 33
Momčilović, B., Al-Khatib, H., Duerre, J. A., Cooley, M., Long, W. M., Harris, T. R., & LYKKEN, G. I. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200104000-00012 · Cited by 33
Lifespan profiles of Alzheimer's disease–associated genes and their products in monkeys and mice
Dosunmu, R., Wu, J.-F., Adwan, L., Maloney, B., Basha, M., McPherson, C., Harry, G., Rice, D., Zawia, N., & Lahiri, D. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1138 · Cited by 31
Self-citationThe effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarray analysis
Cavallaro, R. A., Fuso, A., D’Anselmi, F., Seminara, L., & Scarpa, S. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9407 · Cited by 20
Dc, R. (1992) · PubMed · Cited by 19
Perinatal lead exposure alters the development of δ‐but not μ‐opioid receptors in rat brain
McDowell, J., & Kitchen, I. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11606.x · Cited by 18
Lead Exposure: Expression and Activity Levels of Oct-2 in the Developing Rat Brain
Bakheet, S. A., Basha, R. M., Cai, H., & Zawia, N. H. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl163 · Cited by 13
Self-citation
Cited by
Sorted by citations
Histone acetylation: molecular mnemonics on the chromatin
Gräff, J., & Tsai, L.-H. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3427 · Cited by 680
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 683
Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P. R., Steinbusch, H. W. M., Coleman, P. D., Rutten, B. P. F., & van den Hove, D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.021 · Cited by 442
Clinical and molecular aspects of lead toxicity: An update
Mitra, P., Sharma, S., Purohit, P., & Sharma, P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1408562 · Cited by 402
Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias
Bakulski, K. M., Seo, Y. A., Hickman, R. C., Brandt, D. J., Vadari, H. S., Hu, H., & Park, S. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200282 · Cited by 361
Metadata
- Authors
- Bihaqi, S. W., Huang, H., Wu, J., & Zawia, N. H.
- Affiliations
- University of Rhode Island (US)
- Zhengzhou University (CN)
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2011-12-12
- Volume
- 27
- Issue
- 4
- Pages
- 819-833
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1693568153
- Cited by
- 162
- References
- 60
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 12 · 2016: 15 · 2015: 12 · 2014: 19 · 2013: 14 · 2012: 10
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- Institute of Environmental Science and Research
- National Institute of Environmental Research
- National Institutes of Health
- National Institute of Environmental Health Sciences (R01ES015867)
- National Center for Research Resources (P20RR016457)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- lead exposure
- MeSH terms
- Age Factors, Aging, Animals, Animals, Newborn, Disease Models, Animal, Female, Humans, Lead, Lead Poisoning, Macaca fascicularis, Nerve Tissue Proteins, RNA, Messenger, Transcription Factors, DNA Modification Methylases, Cohort Studies, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, DNA Methylation, rab5 GTP-Binding Proteins, Epigenesis, Genetic, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review